Patents by Inventor Joel S. Karliner

Joel S. Karliner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of interleukin-15 to treat cardiovascular diseases
    Patent number: 9084761
    Abstract: The present disclosure relates generally to the field of cardiovascular diseases. In particular, the present disclosure relates to methods and compositions for treating cardiovascular diseases by administration of a cytokine alone, or in conjunction with other therapeutic agents.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: July 21, 2015
    Assignees: The Regents of the University of California, The United States of America Represented by the Department of Veterans Affairs
    Inventors: Yerem Yeghiazarians, Joel S. Karliner, Andrew Boyle, Franca Angeli, Jean-Philippe Coppe
  • USE OF INTERLEUKIN-15 TO TREAT CARDIOVASCULAR DISEASES
    Publication number: 20130259827
    Abstract: The present disclosure relates generally to the field of cardiovascular diseases. In particular, the present disclosure relates to methods and compositions for treating cardiovascular diseases by administration of a cytokine alone, or in conjunction with other therapeutic agents.
    Type: Application
    Filed: July 8, 2011
    Publication date: October 3, 2013
    Inventors: Yerem Yeghiazarians, Joel S. Karliner, Andrew Boyle, Franca Angeli, Jean-Philippe Coppe
  • PHARMACEUTICAL COMPOSITIONS CONTAINING PYRROLOQUINOLINE QUINONE AND NEPHROPROTECTANT FOR TREATING ISCHEMIA REPERFUSION INJURIES
    Publication number: 20100160367
    Abstract: The invention includes compositions comprising substantially purified pyrroloquinoline quinone, that are useful in methods for the treatment and prevention of cardiac injury caused by hypoxia or ischemia. The invention also includes methods for the treatment and prevention of cardiac injury comprising contacting a composition of the invention with a human patient.
    Type: Application
    Filed: December 22, 2009
    Publication date: June 24, 2010
    Applicant: CLF Medical Technology Acceleration Program, Inc.
    Inventors: Paul J. Davis, Joel S. Karliner, Shaker A. Mousa, George L. Drusano